Clinical Toxicities of Histone Deacetylase Inhibitors

The HDAC inhibitors are a new family of antineoplastic agents. Since the entry of these agents into our therapeutic armamentarium, there has been increasing interest in their use. Although this family comprises chemical compounds from unrelated chemical classes that have different HDAC isoform speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Subramanian, Srividya, Bates, Susan E., Wright, John J., Espinoza-Delgado, Igor, Piekarz, Richard L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034096/
https://www.ncbi.nlm.nih.gov/pubmed/27713375
http://dx.doi.org/10.3390/ph3092751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034096/
https://www.ncbi.nlm.nih.gov/pubmed/27713375
http://dx.doi.org/10.3390/ph3092751

Ejemplares similares